Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bamboos Health Care HoldingsHKSE:02293 53 Return-on-Tangible-Equity is 7.68% as of Dec. 2025, which is 73% below its 10-year median of 28.85. GuruFocus rates HKSE:02293 with a GF Score™ of 53/100 and a GF Value™ of HK$0.37 (Fairly Valued). The stock has 7 warning signs investors should review. Among 1,011 Business Services companies, Bamboos Health Care Holdings ranks worse than 62.51% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Bamboos Health Care Holdings's annualized net income for the quarter that ended in Dec. 2025 was HK$18.57 Mil. Bamboos Health Care Holdings's average shareholder tangible equity for the quarter that ended in Dec. 2025 was HK$241.71 Mil. Therefore, Bamboos Health Care Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 7.68%.
The historical rank and industry rank for Bamboos Health Care Holdings's Return-on-Tangible-Equity or its related term are showing as below:
HKSE:02293'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.1 Med: 28.85 Max: 38.59
Current: 7.1
During the past 13 years, Bamboos Health Care Holdings's highest Return-on-Tangible-Equity was 38.59%. The lowest was 7.10%. And the median was 28.85%.
HKSE:02293's Return-on-Tangible-Equity is ranked worse than 62.51% of 1011
companies
in the Business Services industry
Industry Median: 11.36
vs HKSE:02293: 7.10
Bamboos Health Care Holdings (HKSE:02293) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Bamboos Health Care Holdings Return-on-Tangible-Equity Related Terms
Bamboos Health Care Holdings Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bamboos Health Care Holdings Return-on-Tangible-Equity Chart
HKSE:02293 vs KFY, RHI, TNET: Return-on-Tangible-Equity Comparison
For the Staffing & Employment Services subindustry, Bamboos Health Care Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bamboos Health Care Holdings Return-on-Tangible-Equity vs Business Services Industry
For the Business Services industry and Industrials sector, Bamboos Health Care Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Bamboos Health Care Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 7.68% mean?
Bamboos Health Care Holdings (HKSE:02293) has a Return-on-Tangible-Equity of 7.68% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bamboos Health Care Holdings and its competitors. This is 73% below median its historical median of 28.85. Over the past decade, Bamboos Health Care Holdings' Return-on-Tangible-Equity has ranged from 7.10 to 38.59. According to the industry distribution chart, Bamboos Health Care Holdings ranks #632 out of 1011 companies in the Business Services industry, placing it in the top 62.5%.
Is Bamboos Health Care Holdings' Return-on-Tangible-Equity too high?
Bamboos Health Care Holdings' current Return-on-Tangible-Equity of 7.68% is 73% below median its 10-year median of 28.85. Over the past 10 years, this metric has ranged from a low of 7.10 to a high of 38.59. The Business Services industry median Return-on-Tangible-Equity is 11.36. Bamboos Health Care Holdings' value of 7.68% is 32.4% below this industry median. Based on the distribution chart, Bamboos Health Care Holdings ranks #632 out of 1011 companies in the Business Services industry, which is below the industry midpoint. Overall, Bamboos Health Care Holdings has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bamboos Health Care Holdings' Return-on-Tangible-Equity compare to KFY and RHI?
According to the Business Services industry distribution chart, Bamboos Health Care Holdings ranks #632 out of 1011 companies for Return-on-Tangible-Equity. This places Bamboos Health Care Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 11.36. Bamboos Health Care Holdings' value of 7.68% is 32.4% below this benchmark. Historically, Bamboos Health Care Holdings' own Return-on-Tangible-Equity has ranged from 7.10 to 38.59 over the past decade. While the company's 10-year median is 28.85 vs. the industry median of 11.36, Bamboos Health Care Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Business Services company?
The median Return-on-Tangible-Equity among Business Services companies is 11.36, based on 1,011 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bamboos Health Care Holdings's current Return-on-Tangible-Equity of 7.68% is 32.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bamboos Health Care Holdings and its competitors. For the Business Services industry, the median Return-on-Tangible-Equity is 11.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bamboos Health Care Holdings's current Return-on-Tangible-Equity is 7.68%, which is 73% below median its own 10-year median of 28.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bamboos Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Bamboos Health Care Holdings (HKSE:02293) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.37, compared to a current price of HK$0.36 — trading 2.7% below its estimated fair value. The current Return-on-Tangible-Equity is 7.68%, which is 73% below median its 10-year median of 28.85 and 32.4% below the Business Services industry median of 11.36. Bamboos Health Care Holdings' overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Bamboos Health Care Holdings (HKSE:02293), the current Return-on-Tangible-Equity is 7.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bamboos Health Care Holdings (HKSE:02293) Overvalued in 2026?
Based on GuruFocus' analysis, Bamboos Health Care Holdings stock appears to be undervalued.
The current stock price of HK$0.36 is trading 2.7% below its estimated GF Value™ of HK$0.37.
GuruFocus considers Bamboos Health Care Holdings to be Fairly Valued.
Key valuation signals for HKSE:02293:
Return-on-Tangible-Equity: 7.68% (73% below median its 10-year median of 28.85)
GF Value™: HK$0.37 vs. price of HK$0.36 (2.7% below fair value)
Industry Position: 32.4% below the Business Services median (#632 of 1011)
No single metric tells the full story. See the HKSE:02293 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bamboos Health Care Holdings Ltd is an investment holding company principally engaged in the provision of healthcare staffing solution services. The company serves individuals and institutional clients, including hospitals, social service organizations, and clinics in Hong Kong. It is also engaged in provision of outreach case assessment related services, provision of vaccination services, sales of merchandise and provision of clinic services. The company generates maximum revenue from the provision of healthcare staffing solution services. The company mainly operates in Hong Kong.
53GF Score
Get the complete analysis for HKSE:02293
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02293 has been successfully added to your 
